Patent · US Expired

Chroman derivatives

US5639772A · kind A · utility

10Cited by
9References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 30, 1995
Grant dateJun 17, 1997
Priority date
Expiry dateMay 30, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

3-amino-5-aryl- and 5-heteroarylchromans, as well as enantiomers and salts thereof are disclosed. Pharmaceutical compositions containing the compounds as active ingredients are also disclosed. The compounds are useful in the treatment of 5-hydroxytryptamine-mediated disorders of the central nervous system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.